Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01677572
Brief Title: Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease (PRIME)

First Submitted : August 30, 2012
First Submitted that Met QC Criteria : August 31, 2012
First Posted : September 3, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : July 31, 2020
Last Update Posted : August 3, 2020